Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL BIOMATERIAL IMPLANTS INDUSTRY
2.1 Summary about Biomaterial Implants Industry
2.2 Biomaterial Implants Market Trends
2.2.1 Biomaterial Implants Production & Consumption Trends
2.2.2 Biomaterial Implants Demand Structure Trends
2.3 Biomaterial Implants Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Cardiovascular Implants
4.2.2 Orthopedic Implants
4.2.3 Dental Implants
4.2.4 Other Soft Tissue Implants
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Hospitals
4.3.2 Clinics
4.3.3 Beauty Institutions
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Cardiovascular Implants
5.2.2 Orthopedic Implants
5.2.3 Dental Implants
5.2.4 Other Soft Tissue Implants
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Hospitals
5.3.2 Clinics
5.3.3 Beauty Institutions
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Cardiovascular Implants
6.2.2 Orthopedic Implants
6.2.3 Dental Implants
6.2.4 Other Soft Tissue Implants
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Hospitals
6.3.2 Clinics
6.3.3 Beauty Institutions
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Cardiovascular Implants
7.2.2 Orthopedic Implants
7.2.3 Dental Implants
7.2.4 Other Soft Tissue Implants
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Hospitals
7.3.2 Clinics
7.3.3 Beauty Institutions
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Cardiovascular Implants
8.2.2 Orthopedic Implants
8.2.3 Dental Implants
8.2.4 Other Soft Tissue Implants
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Hospitals
8.3.2 Clinics
8.3.3 Beauty Institutions
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Cardiovascular Implants
9.2.2 Orthopedic Implants
9.2.3 Dental Implants
9.2.4 Other Soft Tissue Implants
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Hospitals
9.3.2 Clinics
9.3.3 Beauty Institutions
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 NuVasive, Inc
10.1.2 Integra LifeSciences Corporation
10.1.3 Edward LifeSciences Corporation
10.1.4 Stryker Corporation
10.1.5 LifeCell corporation
10.1.6 Medtronic
10.1.7 RTI Surgical, Inc
10.1.8 BioPolymer GmbH & Co. KG
10.1.9 Johnson & Johnson
10.1.10 Baxter International, Inc.
10.1.11 Vericel Corporation
10.1.12 Alphatec Spine, Inc
10.1.13 CryoLife
10.1.14 Maxigen Biotech, Inc.
10.1.15 IOP Ophthalmic Products, Inc.
10.1.16 CONMED
10.1.17 Allergan Plc
10.1.18 BioTissue
10.1.19 Auto Tissue Berlin GmbH
10.1.20 MiMedx Group, Inc.
10.1.21 Organogenesis, Inc.
10.1.22 Osiris Therapeutics, Inc.
10.2 Biomaterial Implants Sales Date of Major Players (2017-2020e)
10.2.1 NuVasive, Inc
10.2.2 Integra LifeSciences Corporation
10.2.3 Edward LifeSciences Corporation
10.2.4 Stryker Corporation
10.2.5 LifeCell corporation
10.2.6 Medtronic
10.2.7 RTI Surgical, Inc
10.2.8 BioPolymer GmbH & Co. KG
10.2.9 Johnson & Johnson
10.2.10 Baxter International, Inc.
10.2.11 Vericel Corporation
10.2.12 Alphatec Spine, Inc
10.2.13 CryoLife
10.2.14 Maxigen Biotech, Inc.
10.2.15 IOP Ophthalmic Products, Inc.
10.2.16 CONMED
10.2.17 Allergan Plc
10.2.18 BioTissue
10.2.19 Auto Tissue Berlin GmbH
10.2.20 MiMedx Group, Inc.
10.2.21 Organogenesis, Inc.
10.2.22 Osiris Therapeutics, Inc.
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT